Zhihong Cai

8PUBLICATIONS
34CO-AUTHORS
Traditional Chinese medicine and treatmentsPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 23, 2026
Experience with Tirzepatide and Weight Management During and After a Clinical Trial in Japanese Patients with Obesity Disease: A Qualitative Study.

|Apr 22, 2026
Effectiveness of Galcanezumab and Traditional Oral Migraine Preventive Medications: Interim 3-Month Japan Subgroup Findings from the TRIUMPH Study.

|Feb 07, 2025
Correction to: The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan.

Toshihiko Aranishi, Ataru Igarashi, Kazuo Hara

|Dec 21, 2024
The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan.

Toshihiko Aranishi, Ataru Igarashi, Kazuo Hara

|May 17, 2024
Therapy-Related Satisfaction and Quality of Life for Japanese People with Diabetes Using Rapid-Acting Insulin Analogs: A Web-Based Survey.

Hitoshi Ishii, Yasutaka Maeda, Manaka Sato

|May 01, 2024
Real-World Evidence of FOLFIRI Combined with Anti-Angiogenesis Inhibitors or Anti-EGFR Antibodies for Patients with Early Recurrence Colorectal Cancer After Adjuvant FOLFOX/CAPOX Therapy: A Japanese Claims Database Study.

Yoshinori Kagawa, Chaochen Wang, Yongzhe Piao

Pageof 2

Frequent Collaborators

5 joint publications

Manaka Sato

2 joint publications

Masakazu Takeuchi

2 joint publications

Barnaby Hunt

2 joint publications

Beatrice Osumili